ProFunds Pharmaceuticals UltraSector Svc (PHPSX)
| Fund Assets | 3.51M |
| Expense Ratio | 2.78% |
| Min. Investment | $5,000 |
| Turnover | 207.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 22.72 |
| YTD Return | 7.32% |
| 1-Year Return | 5.17% |
| 5-Year Return | 23.80% |
| 52-Week Low | 15.87 |
| 52-Week High | 24.50 |
| Beta (5Y) | 0.87 |
| Holdings | 52 |
| Inception Date | Jun 28, 2000 |
About PHPSX
ProFunds Pharmaceuticals UltraSector Fund Service Class is a leveraged mutual fund designed to magnify exposure to the U.S. pharmaceuticals sector. Its primary objective is to provide daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the S&P Pharmaceuticals Select Industry Index. To achieve this, the fund invests primarily in derivatives and other financial instruments that enable leveraged exposure, rather than holding the underlying equities directly. This structure allows the fund to respond dynamically to market movements within the pharmaceutical industry on a daily basis, offering the potential for amplified returns as well as increased volatility. The fund plays a distinct role in the financial market by catering to investors seeking tactical, short-term access to the pharmaceuticals sector with enhanced sensitivity to daily price changes. It reflects broad industry trends driven by innovation, regulation, and consumer health dynamics. Notably, this leveraged strategy makes the fund particularly sensitive to both gains and losses, emphasizing its suitability for sophisticated investors who monitor positions regularly. With a low portfolio carbon risk score and minimal fossil fuel exposure, the fund also aligns with certain sustainability considerations within the healthcare investment space.
Performance
PHPSX had a total return of 5.17% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.54%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| PHPIX | Investor Class | 1.78% |
Top 10 Holdings
33.79% of assets| Name | Symbol | Weight |
|---|---|---|
| SOCIETE' GENERALE 4.23 , 5/01/2025 | n/a | 5.90% |
| HSBC SECURITIES (USA), INC. 4.28 , 5/01/2025 | n/a | 5.61% |
| Corcept Therapeutics Incorporated | CORT | 3.52% |
| Eli Lilly and Company | LLY | 2.95% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.83% |
| Royalty Pharma plc | RPRX | 2.69% |
| Zoetis Inc. | ZTS | 2.61% |
| Johnson & Johnson | JNJ | 2.59% |
| Pfizer Inc. | PFE | 2.56% |
| Axsome Therapeutics, Inc. | AXSM | 2.53% |